HQP Development Committee

DEDICATED TO TRAINING THE NEXT GENERATION

 

BioCanRx’s mission is to build and foster a network that accelerates Canada’s most promising biologically based cancer therapies into clinical trials. An essential component of BioCanRx’s success in achieving this mandate is training and development of highly qualified personnel (HQP) who are skilled in all aspects of clinical translation, from bench to clinic. For this reason, BioCanRx’s training mandate is targeted at HQP working in all relevant disciplines (e.g, virology, immunology, health policy, implementation and knowledge translation) and at all training and professional levels (e.g., from high school students to senior research and clinical staff).

 

The BioCanRx HQP Development Committee advises on training programs and initiatives, which consists of network investigators, technical staff leadership, industry partners, charities and HQP representatives from the BioCanRx network.

 

CURRENT COMMITTEE MEMBERS

 

CHAIR

 

Harold Atkins, MD
Chair, HQP Development Committee, BioCanRx
Clinician Scientist, The Ottawa Hospital

 

MEMBERS

 

Raja Ghosh, PhD
Professor, McMaster University

 

Bruce Seet, PhD
Director of Medical Affairs, Sanofi Pasteur

 

Linh Nguyen, PhD
Scientific Associate, University Health Network

 

Carolina Ilkow, PhD
Assistant Professor, University of Ottawa

 

Risini Weeratna, PhD
Senior Research Officer, National Research Council of Canada

 

Megan Mahoney, PhD
Director of Scientific Affairs and Training Programs

 

Jennifer Quizi, PhD
Director of Biotherapeutics Manufacturing Operations, BioCanRx

 

Julian Lum, PhD
Senior Scientist, BC Cancer; Associate Prof., University of Victoria

 

Karin Hermans, PhD
Senior Research Associate, Donna Wall Lab (SickKids)

 

OBSERVER

 

François Santerre
Senior Program Manager, College and Networks, Networks of Centres of Excellence (NCE)